Related Experiment Video

Updated: Jun 27, 2026

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

Cardiac disease in myasthenia gravis: a literature review

Maya Guglin1, Joseph V Campellone, Kathleen Heintz

  • 1From the Department of Medicine, Divisions of *Cardiology and daggerNeurology, Cooper Hospital/University Medical Center, Robert Wood Johnson Medical School, Camden, NJ.

Journal of Clinical Neuromuscular Disease
|December 17, 2008
PubMed

Insights

Myasthenia gravis patients may experience cardiac disorders, but a direct cause is unproven. Research is needed to understand cardiac disease and sudden death causes in these patients.

Area of Science:

  • Neurology
  • Cardiology

Background:

  • Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
  • Cardiac complications in MG patients are reported but not fully understood.
  • Sudden death causes in MG are often undetermined, suggesting potential cardiac involvement.

Purpose of the Study:

  • To review the current literature on cardiac disorders in myasthenia gravis patients.
  • To explore potential etiologies of cardiac disease in this population.
  • To discuss the implications of cardiac disease in myasthenia gravis.

Main Methods:

  • Literature review and synthesis of existing studies.
  • Analysis of reported cardiac conditions in myasthenia gravis patients.
  • Discussion of potential causal links and clinical significance.

Main Results:

  • Various cardiac disorders have been observed in patients with myasthenia gravis.
  • A definitive causal relationship between myasthenia gravis and cardiac disorders is not yet established.
  • Cardiac disease may contribute to unexplained sudden death in this cohort.

Conclusions:

  • Cardiac involvement is a significant concern in myasthenia gravis management.
  • Further research is warranted to elucidate the link between MG and cardiac pathology.
  • Identifying cardiac risks is crucial for improving outcomes and understanding mortality in myasthenia gravis.

More Related Videos

Antigenic Liposomes for Generation of Disease-specific Antibodies10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...